ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,126 | -68.9% | 13,287 | +22.0% | 0.00% | -100.0% |
| Q4 2022 | $67,851 | -60.6% | 10,891 | -68.3% | 0.00% | 0.0% |
| Q4 2021 | $172,000 | -91.8% | 34,327 | -65.3% | 0.00% | -92.3% |
| Q2 2021 | $2,092,000 | -32.1% | 98,918 | -9.9% | 0.01% | -38.1% |
| Q1 2021 | $3,080,000 | +296.9% | 109,815 | +267.8% | 0.02% | +162.5% |
| Q4 2020 | $776,000 | -60.2% | 29,861 | -43.1% | 0.01% | -66.7% |
| Q3 2020 | $1,949,000 | +72.9% | 52,436 | +138.8% | 0.02% | +50.0% |
| Q2 2020 | $1,127,000 | -39.7% | 21,960 | -30.0% | 0.02% | -44.8% |
| Q4 2019 | $1,870,000 | -46.0% | 31,356 | -66.8% | 0.03% | -46.3% |
| Q3 2019 | $3,462,000 | -20.2% | 94,434 | +1.3% | 0.05% | -28.9% |
| Q2 2019 | $4,338,000 | +57.1% | 93,259 | +35.6% | 0.08% | +72.7% |
| Q1 2019 | $2,761,000 | – | 68,770 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |